MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CELG-RI made $11,489M in revenue. $2,677M in net income. Net profit margin of 23.30%.

Income Overview

Revenue
$11,489M
Net Income
$2,677M
Net Profit Margin
23.30%
EPS
$1.31
Unit: Million (M) dollars
Revenue Breakdown
    • Revenues
    • Other Revenues
    • Alliance Revenues
Revenue Breakdown
    • Revenues
    • Alliance And Other Revenues
Revenue Breakdown
    • Eliquis
    • Opdivo
    • Orencia
    • Others
Revenue Breakdown
    • US
    • Non Us
    • Other Region

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
11,489 12,502 12,222 12,269
Cost of products sold
3,421 4,096 3,435 3,372
Selling, general and administrative
1,617 2,181 1,789 1,713
Research and development
2,649 2,586 2,528 2,580
Acquired iprd
94 1,392 633 1,508
Loss on debt redemption (note 10)
--89* --
Amortization of acquired intangible assets
437 826 831 830
Contingent consideration (note 9)
0 281* 0 -
Intangible asset impairment
0 -0 -
Acquisition expense
0 4 0 -
Interest expense
411 432 480 -
Royalty income - divestitures (note 4)
0 285 286 -
Royalty and licensing income (note 4)
195 396 276 -
Investment income
104 148 161 -
Provision for restructuring (note 6)
5 132 75 -
Litigation and other settlements
-4 -11 -165 -
Equity investment (gains)/losses, net (note 9)
134 190 190 -
Integration expenses (note 6)
19 38 36 -
Other
-27 19 -48 -
Other (income)/expense, net
-32 51 108 -494
Total expenses
8,250 11,032 9,108 10,496
Earnings/(loss) before income taxes
3,240 1,469 3,114 1,773
Income tax provision
561 384 919 460
Net earnings/(loss)
2,678 1,085 2,195 1,313
Noncontrolling interest
1 0 -6 2
Net earnings/(loss) attributable to bms
2,677 1,087 2,201 1,310
Basic EPS
1.31 0.534 1.08 0.64
Diluted EPS
1.31 0.533 1.08 0.64
Basic Average Shares
2,038,000,000 2,034,000,000 2,036,000,000 2,035,000,000
Diluted Average Shares
2,047,000,000 2,039,000,000 2,039,000,000 2,038,000,000
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Revenues$16,926M (-14.83%↓ Y/Y)Net Product Sales$11,168M (2.59%↑ Y/Y)Other Revenues$227M (0.00%↑ Y/Y)Alliance Revenues$94M Total gtn adjustments-$5,758M (35.94%↑ Y/Y)Total revenues$11,489M (2.57%↑ Y/Y)Chargebacksandcashdiscounts-$2,467M (16.60%↑ Y/Y)MedicaidandMedicarerebates-$1,875M (51.17%↑ Y/Y)Other Rebates ReturnsDiscounts And Adjustments-$1,416M Earnings/(loss) before incometaxes$3,240M (9.05%↑ Y/Y)Total expenses$8,250M (0.24%↑ Y/Y)Netearnings/(loss)$2,678M (8.77%↑ Y/Y)Income tax provision$561M (10.22%↑ Y/Y)Cost of products sold$3,421M (12.79%↑ Y/Y)Research and development$2,649M (17.37%↑ Y/Y)Selling, general andadministrative$1,617M (2.08%↑ Y/Y)Amortization of acquiredintangible assets$437M (-47.35%↓ Y/Y)Acquired iprd$94M (-50.00%↓ Y/Y)Other(income)/expense, net-$32M (90.56%↑ Y/Y)Royalty and licensingincome (note 4)$195M (-24.71%↓ Y/Y)Equity investment(gains)/losses, net (note 9)$134M (271.79%↑ Y/Y)Investment income$104M (-24.64%↓ Y/Y)Netearnings/(loss) attributable to...$2,677M (9.00%↑ Y/Y)Noncontrolling interest$1M (-83.33%↓ Y/Y)Interest expense$411M (-16.80%↓ Y/Y)Other-$27M (-800.00%↓ Y/Y)Integration expenses (note6)$19M (-53.66%↓ Y/Y)Provision forrestructuring (note 6)$5M (-96.24%↓ Y/Y)Litigation and othersettlements-$4M (98.44%↑ Y/Y)

BRISTOL MYERS SQUIBB CO (CELG-RI)

BRISTOL MYERS SQUIBB CO (CELG-RI)